Insider Title Company Date Price Return Shares Value
Friedman Cathy Non-Executive Director Lyell Immunopharma, Inc. (LYEL) 2021-06-21 $17.00 -92.5% 17,648 $300,016
Return Profit / (loss) Cost
Total -92.5% $-277,427 $300,016